Cite Filings / BTAIQ / 0001104659-23-101769
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

BioXcel Therapeutics, Inc. · Filed 2023-09-19 · Acc 0001104659-23-101769

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , tm2326397d1_8k.htm

Around this filing

  • 2023-09-25 8-K Material agreement · Executive or director change
  • 2023-09-19 8-K Other events
  • 2023-09-18 4 Chief Scientific Officer acquired 521 shares (option exercise)
  • 2023-09-18 4 Rodriguez Javier acquired 521 shares (option exercise)
  • 2023-09-18 4 Chief Medical Officer acquired 521 shares (option exercise)
  • 2023-09-18 4 CEO and President acquired 2,610 shares (option exercise)
  • 2023-09-12 8-K Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2326397d1_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…